This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-141-3p | ABL1 | 5.02 | 0 | -1.32 | 0 | MirTarget | -0.18 | 0 | NA | |
2 | hsa-miR-141-3p | ABL2 | 5.02 | 0 | -0.32 | 0.04554 | MirTarget; TargetScan; miRNATAP | -0.13 | 0 | NA | |
3 | hsa-miR-141-3p | ACO1 | 5.02 | 0 | -0.65 | 0.00055 | MirTarget; TargetScan | -0.13 | 0 | NA | |
4 | hsa-miR-141-3p | ADARB1 | 5.02 | 0 | -1.93 | 0 | MirTarget | -0.34 | 0 | NA | |
5 | hsa-miR-141-3p | AFAP1 | 5.02 | 0 | -0.98 | 0.00012 | mirMAP | -0.24 | 0 | NA | |
6 | hsa-miR-141-3p | AKAP2 | 5.02 | 0 | -2.51 | 8.0E-5 | TargetScan | -0.59 | 0 | NA | |
7 | hsa-miR-141-3p | AMOTL1 | 5.02 | 0 | -1.62 | 0 | TargetScan | -0.26 | 0 | NA | |
8 | hsa-miR-141-3p | AMZ1 | 5.02 | 0 | 0.48 | 0.33638 | mirMAP | -0.17 | 0.00019 | NA | |
9 | hsa-miR-141-3p | ANGPTL1 | 5.02 | 0 | -4.51 | 0 | MirTarget | -0.76 | 0 | NA | |
10 | hsa-miR-141-3p | ANK2 | 5.02 | 0 | -4.32 | 0 | TargetScan; miRNATAP | -0.68 | 0 | NA | |
11 | hsa-miR-141-3p | ANKRD44 | 5.02 | 0 | -1.93 | 0 | TargetScan | -0.35 | 0 | NA | |
12 | hsa-miR-141-3p | ANO5 | 5.02 | 0 | -3.19 | 0 | mirMAP | -0.3 | 0 | NA | |
13 | hsa-miR-141-3p | APBB2 | 5.02 | 0 | -0.59 | 0.0014 | MirTarget; TargetScan | -0.17 | 0 | NA | |
14 | hsa-miR-141-3p | APOLD1 | 5.02 | 0 | -2.62 | 0 | TargetScan | -0.24 | 0 | NA | |
15 | hsa-miR-141-3p | ARHGAP24 | 5.02 | 0 | -2.02 | 0 | TargetScan; miRNATAP | -0.38 | 0 | NA | |
16 | hsa-miR-141-3p | ARID5B | 5.02 | 0 | -1.57 | 0 | TargetScan; miRNATAP | -0.16 | 0 | NA | |
17 | hsa-miR-141-3p | ARL10 | 5.02 | 0 | -1.12 | 0.00198 | mirMAP | -0.25 | 0 | NA | |
18 | hsa-miR-141-3p | ARL4A | 5.02 | 0 | -0.62 | 0.01525 | TargetScan | -0.1 | 1.0E-5 | NA | |
19 | hsa-miR-141-3p | ARNT2 | 5.02 | 0 | -1.45 | 0.00019 | mirMAP | -0.13 | 0.00022 | NA | |
20 | hsa-miR-141-3p | ARNTL | 5.02 | 0 | -0.36 | 0.08956 | MirTarget; TargetScan; miRNATAP | -0.1 | 0 | NA | |
21 | hsa-miR-141-3p | ASB1 | 5.02 | 0 | -0.87 | 0 | mirMAP | -0.12 | 0 | NA | |
22 | hsa-miR-141-3p | ASTN1 | 5.02 | 0 | -2.34 | 2.0E-5 | MirTarget; miRNATAP | -0.14 | 0.00582 | NA | |
23 | hsa-miR-141-3p | ASXL3 | 5.02 | 0 | -3.34 | 0 | TargetScan | -0.31 | 0 | NA | |
24 | hsa-miR-141-3p | ATP8A1 | 5.02 | 0 | -1.48 | 8.0E-5 | MirTarget; TargetScan | -0.16 | 1.0E-5 | NA | |
25 | hsa-miR-141-3p | ATXN1 | 5.02 | 0 | -1.51 | 0 | MirTarget; TargetScan; miRNATAP | -0.24 | 0 | NA | |
26 | hsa-miR-141-3p | BACE1 | 5.02 | 0 | -0.72 | 0.00096 | TargetScan; miRNATAP | -0.22 | 0 | NA | |
27 | hsa-miR-141-3p | BACH2 | 5.02 | 0 | -1.52 | 0.00134 | TargetScan | -0.49 | 0 | NA | |
28 | hsa-miR-210-3p | BDNF | 6.07 | 0 | -2.91 | 0 | miRNAWalker2 validate; miRTarBase | -0.24 | 0 | NA | |
29 | hsa-miR-141-3p | BEND4 | 5.02 | 0 | -1.97 | 7.0E-5 | TargetScan; miRNATAP | -0.29 | 0 | NA | |
30 | hsa-miR-141-3p | BNC2 | 5.02 | 0 | -2.95 | 0 | TargetScan | -0.63 | 0 | NA | |
31 | hsa-miR-141-3p | BVES | 5.02 | 0 | -2.76 | 0 | mirMAP | -0.48 | 0 | NA | |
32 | hsa-miR-141-3p | C11orf21 | 5.02 | 0 | -1.31 | 0.00227 | mirMAP | -0.24 | 0 | NA | |
33 | hsa-miR-141-3p | CACNA2D1 | 5.02 | 0 | -3.32 | 0 | TargetScan | -0.71 | 0 | NA | |
34 | hsa-miR-141-3p | CADM1 | 5.02 | 0 | -1.19 | 0.01251 | MirTarget; TargetScan | -0.16 | 0.00033 | NA | |
35 | hsa-miR-141-3p | CADM2 | 5.02 | 0 | -3.84 | 0 | TargetScan; miRNATAP | -0.3 | 0 | NA | |
36 | hsa-miR-141-3p | CALU | 5.02 | 0 | -0.15 | 0.46318 | TargetScan | -0.2 | 0 | NA | |
37 | hsa-miR-141-3p | CAMK4 | 5.02 | 0 | -1.28 | 0.0022 | mirMAP | -0.29 | 0 | NA | |
38 | hsa-miR-141-3p | CCDC80 | 5.02 | 0 | -3.33 | 0 | MirTarget; TargetScan | -0.69 | 0 | NA | |
39 | hsa-miR-141-3p | CCND2 | 5.02 | 0 | -2.43 | 0 | MirTarget; TargetScan | -0.34 | 0 | NA | |
40 | hsa-miR-141-3p | CCPG1 | 5.02 | 0 | -1 | 0 | MirTarget; miRNATAP | -0.19 | 0 | NA | |
41 | hsa-miR-141-3p | CD274 | 5.02 | 0 | 0.06 | 0.90454 | MirTarget | -0.22 | 0 | NA | |
42 | hsa-miR-141-3p | CD59 | 5.02 | 0 | -0.7 | 0.0013 | mirMAP | -0.1 | 0 | NA | |
43 | hsa-miR-141-3p | CDC25B | 5.02 | 0 | 0.78 | 0.00479 | TargetScan | -0.12 | 0 | NA | |
44 | hsa-miR-141-3p | CDC42EP3 | 5.02 | 0 | -1.35 | 0 | MirTarget; TargetScan | -0.22 | 0 | NA | |
45 | hsa-miR-141-3p | CDK6 | 5.02 | 0 | -0.77 | 0.06479 | TargetScan; miRNATAP | -0.28 | 0 | NA | |
46 | hsa-miR-141-3p | CDON | 5.02 | 0 | -2.61 | 0 | TargetScan; miRNATAP | -0.4 | 0 | NA | |
47 | hsa-miR-141-3p | CDV3 | 5.02 | 0 | -0.42 | 0.0021 | TargetScan; miRNATAP | -0.11 | 0 | NA | |
48 | hsa-miR-141-3p | CELF2 | 5.02 | 0 | -3.05 | 0 | mirMAP; miRNATAP | -0.47 | 0 | NA | |
49 | hsa-miR-141-3p | CEP170 | 5.02 | 0 | -0.11 | 0.58268 | TargetScan | -0.14 | 0 | NA | |
50 | hsa-miR-141-3p | CFL2 | 5.02 | 0 | -2.62 | 0 | TargetScan | -0.42 | 0 | NA | |
51 | hsa-miR-141-3p | CHRDL1 | 5.02 | 0 | -6.15 | 0 | MirTarget; TargetScan | -0.9 | 0 | NA | |
52 | hsa-miR-141-3p | CLIC4 | 5.02 | 0 | -1.72 | 0 | MirTarget | -0.4 | 0 | NA | |
53 | hsa-miR-141-3p | CLIP2 | 5.02 | 0 | -0.8 | 0.00158 | MirTarget; TargetScan | -0.15 | 0 | NA | |
54 | hsa-miR-141-3p | CNTN1 | 5.02 | 0 | -4.98 | 0 | MirTarget; TargetScan; miRNATAP | -0.75 | 0 | NA | |
55 | hsa-miR-141-3p | COL11A1 | 5.02 | 0 | 4.69 | 0 | miRNATAP | -0.23 | 0.00397 | NA | |
56 | hsa-miR-141-3p | COL15A1 | 5.02 | 0 | -0.94 | 0.00988 | MirTarget | -0.34 | 0 | NA | |
57 | hsa-miR-141-3p | COL8A1 | 5.02 | 0 | -0.75 | 0.115 | mirMAP | -0.38 | 0 | NA | |
58 | hsa-miR-141-3p | CORO1C | 5.02 | 0 | -1.12 | 0 | TargetScan | -0.25 | 0 | NA | |
59 | hsa-miR-210-3p | CORO2B | 6.07 | 0 | -2.03 | 0 | MirTarget | -0.22 | 0 | NA | |
60 | hsa-miR-141-3p | CPEB4 | 5.02 | 0 | -1.56 | 0 | TargetScan | -0.12 | 0 | NA | |
61 | hsa-miR-141-3p | CREB5 | 5.02 | 0 | -2.28 | 0 | mirMAP | -0.41 | 0 | NA | |
62 | hsa-miR-141-3p | CRMP1 | 5.02 | 0 | -1.11 | 0.00158 | MirTarget; TargetScan | -0.23 | 0 | NA | |
63 | hsa-miR-141-3p | CSF3 | 5.02 | 0 | -4.55 | 0 | TargetScan; miRNATAP | -0.54 | 0 | NA | |
64 | hsa-miR-141-3p | CTSB | 5.02 | 0 | 0.1 | 0.67673 | mirMAP | -0.17 | 0 | NA | |
65 | hsa-miR-141-3p | CTTNBP2 | 5.02 | 0 | -2.9 | 1.0E-5 | miRNATAP | -0.24 | 7.0E-5 | NA | |
66 | hsa-miR-141-3p | CXCL12 | 5.02 | 0 | -3.26 | 0 | miRNATAP | -0.58 | 0 | NA | |
67 | hsa-miR-141-3p | CYLD | 5.02 | 0 | -0.89 | 0 | mirMAP | -0.14 | 0 | NA | |
68 | hsa-miR-141-3p | CYP26B1 | 5.02 | 0 | -0.69 | 0.15191 | MirTarget; TargetScan; miRNATAP | -0.38 | 0 | NA | |
69 | hsa-miR-141-3p | DIO2 | 5.02 | 0 | -0.24 | 0.63454 | miRNATAP | -0.29 | 0 | NA | |
70 | hsa-miR-141-3p | DLC1 | 5.02 | 0 | -1.8 | 0 | TargetScan; miRNATAP | -0.21 | 0 | 26278151 | MicroRNA 141 regulates the tumour suppressor DLC1 in colorectal cancer; Luciferase reporter assays and Western blots showed that DLC1 was a direct target of miR-141 in CRC; The expression levels of miR-141 were obviously up-regulated in CRC tissues compared to non-cancerous tissues while DLC1 expression levels were down-regulated in a high proportion of clinical samples 14/18; In addition correlation analyses revealed negative correlation between miR-141 levels and DLC1 expression levels in CRC tissues; In conclusion we demonstrated that miR-141 is up-regulated in CRC and acts as a functional oncogene by targeting DLC1 |
71 | hsa-miR-141-3p | DOCK4 | 5.02 | 0 | -0.48 | 0.07912 | MirTarget; TargetScan | -0.18 | 0 | NA | |
72 | hsa-miR-141-3p | DPYSL3 | 5.02 | 0 | -2.32 | 0 | TargetScan | -0.54 | 0 | NA | |
73 | hsa-miR-141-3p | DSEL | 5.02 | 0 | -1.79 | 0 | TargetScan | -0.29 | 0 | NA | |
74 | hsa-miR-141-3p | DST | 5.02 | 0 | -1.12 | 9.0E-5 | mirMAP | -0.12 | 0 | NA | |
75 | hsa-miR-141-3p | DUSP1 | 5.02 | 0 | -3.47 | 0 | TargetScan | -0.34 | 0 | NA | |
76 | hsa-miR-141-3p | DUSP3 | 5.02 | 0 | -1.04 | 0 | MirTarget; TargetScan; miRNATAP | -0.15 | 0 | NA | |
77 | hsa-miR-141-3p | DYNC1I1 | 5.02 | 0 | -2.05 | 0.0001 | MirTarget | -0.21 | 1.0E-5 | NA | |
78 | hsa-miR-141-3p | DZIP1 | 5.02 | 0 | -1.57 | 2.0E-5 | TargetScan; miRNATAP | -0.29 | 0 | NA | |
79 | hsa-miR-141-3p | EGR2 | 5.02 | 0 | -2.81 | 0 | TargetScan; miRNATAP | -0.47 | 0 | NA | |
80 | hsa-miR-210-3p | ELFN2 | 6.07 | 0 | -0.56 | 0.36612 | MirTarget | -0.17 | 0.00076 | NA | |
81 | hsa-miR-141-3p | ELK3 | 5.02 | 0 | -0.31 | 0.25641 | TargetScan | -0.19 | 0 | NA | |
82 | hsa-miR-141-3p | ELL2 | 5.02 | 0 | -1.08 | 1.0E-5 | TargetScan | -0.13 | 0 | NA | |
83 | hsa-miR-141-3p | ENAH | 5.02 | 0 | -0.68 | 0.00063 | TargetScan | -0.15 | 0 | NA | |
84 | hsa-miR-141-3p | EPB41L3 | 5.02 | 0 | -1.63 | 7.0E-5 | miRNATAP | -0.29 | 0 | NA | |
85 | hsa-miR-141-3p | EPHA7 | 5.02 | 0 | -4.2 | 0 | TargetScan; miRNATAP | -0.33 | 0 | 26261572 | Among those the expression of EPHA7 and PI15 were negatively correlated with that of microRNA-141 and they were also identified as potential targets of this microRNA via microRNA-mRNA interaction; We thus concluded that microRNA-141 EPHA7 and PI15 might jointly participate in the regulation of drug resistance in ovarian cancer and serve as potential targets in targeted therapies |
86 | hsa-miR-141-3p | ERC2 | 5.02 | 0 | -0.08 | 0.86617 | MirTarget; TargetScan | -0.11 | 0.01934 | NA | |
87 | hsa-miR-141-3p | ERG | 5.02 | 0 | -1.35 | 0 | MirTarget; TargetScan | -0.25 | 0 | NA | |
88 | hsa-miR-141-3p | ETS1 | 5.02 | 0 | -0.7 | 0.00228 | mirMAP | -0.14 | 0 | NA | |
89 | hsa-miR-141-3p | FAM133A | 5.02 | 0 | -0.54 | 0.49453 | mirMAP | -0.31 | 1.0E-5 | NA | |
90 | hsa-miR-141-3p | FAM167A | 5.02 | 0 | 0.27 | 0.48779 | mirMAP | -0.19 | 0 | NA | |
91 | hsa-miR-141-3p | FAM168A | 5.02 | 0 | -0.72 | 0.00481 | TargetScan | -0.17 | 0 | NA | |
92 | hsa-miR-141-3p | FAM168B | 5.02 | 0 | -0.95 | 0 | MirTarget; TargetScan | -0.11 | 0 | NA | |
93 | hsa-miR-141-3p | FAM20C | 5.02 | 0 | -1.33 | 0.00181 | MirTarget | -0.46 | 0 | NA | |
94 | hsa-miR-141-3p | FAM26E | 5.02 | 0 | -1.51 | 4.0E-5 | mirMAP | -0.41 | 0 | NA | |
95 | hsa-miR-141-3p | FAM46C | 5.02 | 0 | -1.66 | 0 | TargetScan; miRNATAP | -0.11 | 0.00024 | NA | |
96 | hsa-miR-141-3p | FAT3 | 5.02 | 0 | -2.79 | 0 | MirTarget; miRNATAP | -0.24 | 1.0E-5 | NA | |
97 | hsa-miR-141-3p | FER | 5.02 | 0 | -0.96 | 0.00017 | mirMAP | -0.18 | 0 | NA | |
98 | hsa-miR-141-3p | FGF13 | 5.02 | 0 | -2.8 | 0 | TargetScan | -0.3 | 0 | NA | |
99 | hsa-miR-141-3p | FKBP5 | 5.02 | 0 | -1.54 | 4.0E-5 | TargetScan | -0.39 | 0 | NA | |
100 | hsa-miR-141-3p | FLI1 | 5.02 | 0 | -1.11 | 7.0E-5 | TargetScan | -0.28 | 0 | NA | |
101 | hsa-miR-141-3p | FNIP2 | 5.02 | 0 | -0.76 | 0.01045 | TargetScan | -0.15 | 0 | NA | |
102 | hsa-miR-141-3p | FOXN3 | 5.02 | 0 | -1.44 | 0 | MirTarget; TargetScan; miRNATAP | -0.14 | 0 | NA | |
103 | hsa-miR-141-3p | FOXP2 | 5.02 | 0 | -3.99 | 0 | TargetScan | -0.49 | 0 | NA | |
104 | hsa-miR-141-3p | FRMD6 | 5.02 | 0 | -0.93 | 0.00183 | MirTarget; TargetScan; miRNATAP | -0.12 | 2.0E-5 | NA | |
105 | hsa-miR-141-3p | FSD1L | 5.02 | 0 | -0.15 | 0.71855 | TargetScan | -0.29 | 0 | NA | |
106 | hsa-miR-141-3p | FTO | 5.02 | 0 | -0.52 | 0.0001 | mirMAP | -0.1 | 0 | NA | |
107 | hsa-miR-141-3p | FYCO1 | 5.02 | 0 | -1.62 | 0 | mirMAP | -0.12 | 0 | NA | |
108 | hsa-miR-141-3p | FZD4 | 5.02 | 0 | -0.83 | 0.00068 | TargetScan | -0.11 | 0 | NA | |
109 | hsa-miR-141-3p | GAB2 | 5.02 | 0 | -1.2 | 0 | mirMAP | -0.13 | 0 | NA | |
110 | hsa-miR-141-3p | GATA6 | 5.02 | 0 | -3.38 | 0 | TargetScan; miRNATAP | -0.51 | 0 | NA | |
111 | hsa-miR-141-3p | GCNT2 | 5.02 | 0 | -0.71 | 0.08266 | TargetScan | -0.11 | 0.00337 | NA | |
112 | hsa-miR-141-3p | GDF6 | 5.02 | 0 | -1.14 | 0.02791 | TargetScan | -0.34 | 0 | NA | |
113 | hsa-miR-141-3p | GEM | 5.02 | 0 | -3.69 | 0 | MirTarget | -0.59 | 0 | NA | |
114 | hsa-miR-141-3p | GFRA1 | 5.02 | 0 | -5 | 0 | mirMAP | -0.39 | 0 | NA | |
115 | hsa-miR-141-3p | GFRA2 | 5.02 | 0 | -3.22 | 0 | mirMAP | -0.44 | 0 | NA | |
116 | hsa-miR-141-3p | GJC1 | 5.02 | 0 | -0.97 | 0.00222 | MirTarget; TargetScan; miRNATAP | -0.25 | 0 | NA | |
117 | hsa-miR-141-3p | GLI2 | 5.02 | 0 | -2.29 | 0 | MirTarget | -0.49 | 0 | NA | |
118 | hsa-miR-141-3p | GLRX | 5.02 | 0 | -0.28 | 0.31677 | MirTarget; TargetScan; miRNATAP | -0.13 | 0 | NA | |
119 | hsa-miR-141-3p | GNA12 | 5.02 | 0 | -0.33 | 0.08399 | mirMAP | -0.16 | 0 | NA | |
120 | hsa-miR-141-3p | GNE | 5.02 | 0 | -0.89 | 0.00299 | MirTarget | -0.13 | 0 | NA | |
121 | hsa-miR-141-3p | GNG4 | 5.02 | 0 | 0.22 | 0.74468 | mirMAP | -0.31 | 0 | NA | |
122 | hsa-miR-141-3p | GNG7 | 5.02 | 0 | -3.48 | 0 | MirTarget; TargetScan; miRNATAP | -0.3 | 0 | NA | |
123 | hsa-miR-141-3p | GPC6 | 5.02 | 0 | -2.71 | 0 | TargetScan | -0.64 | 0 | NA | |
124 | hsa-miR-141-3p | GPD1 | 5.02 | 0 | -1.45 | 0.00526 | TargetScan | -0.19 | 6.0E-5 | NA | |
125 | hsa-miR-141-3p | GPM6B | 5.02 | 0 | -2.39 | 0 | TargetScan; miRNATAP | -0.3 | 0 | NA | |
126 | hsa-miR-141-3p | GPR174 | 5.02 | 0 | -0.71 | 0.15454 | TargetScan | -0.28 | 0 | NA | |
127 | hsa-miR-141-3p | GPR63 | 5.02 | 0 | -0.92 | 0.01437 | TargetScan | -0.15 | 1.0E-5 | NA | |
128 | hsa-miR-141-3p | GPRC5B | 5.02 | 0 | -0.92 | 0.00843 | mirMAP | -0.17 | 0 | NA | |
129 | hsa-miR-141-3p | GRAP2 | 5.02 | 0 | -1.99 | 0 | mirMAP | -0.34 | 0 | NA | |
130 | hsa-miR-141-3p | GRIK3 | 5.02 | 0 | -4.42 | 0 | mirMAP | -0.34 | 0 | NA | |
131 | hsa-miR-141-3p | GRIN3A | 5.02 | 0 | -0.24 | 0.40319 | TargetScan; miRNATAP | -0.19 | 0 | NA | |
132 | hsa-miR-141-3p | GSN | 5.02 | 0 | -2.39 | 0 | MirTarget | -0.26 | 0 | NA | |
133 | hsa-miR-141-3p | HAS2 | 5.02 | 0 | -1.45 | 0.00631 | MirTarget | -0.37 | 0 | NA | |
134 | hsa-miR-141-3p | HDAC4 | 5.02 | 0 | -1.8 | 0 | TargetScan; miRNATAP | -0.22 | 0 | NA | |
135 | hsa-miR-141-3p | HECW1 | 5.02 | 0 | 0.08 | 0.87699 | TargetScan | -0.23 | 0 | NA | |
136 | hsa-miR-141-3p | HEYL | 5.02 | 0 | -0.31 | 0.27592 | mirMAP | -0.21 | 0 | NA | |
137 | hsa-miR-141-3p | HGF | 5.02 | 0 | -2.97 | 0 | MirTarget; TargetScan | -0.68 | 0 | NA | |
138 | hsa-miR-141-3p | HIPK3 | 5.02 | 0 | -1.75 | 0 | MirTarget; TargetScan | -0.22 | 0 | NA | |
139 | hsa-miR-141-3p | HIVEP3 | 5.02 | 0 | 0.03 | 0.92033 | mirMAP | -0.17 | 0 | NA | |
140 | hsa-miR-141-3p | HLF | 5.02 | 0 | -5.48 | 0 | TargetScan | -0.59 | 0 | NA | |
141 | hsa-miR-141-3p | HOXA11 | 5.02 | 0 | -0.78 | 0.02922 | TargetScan; miRNATAP | -0.12 | 0.00017 | NA | |
142 | hsa-miR-141-3p | HS3ST3B1 | 5.02 | 0 | -0.64 | 0.18337 | mirMAP | -0.38 | 0 | NA | |
143 | hsa-miR-141-3p | HSPA13 | 5.02 | 0 | -0.29 | 0.10635 | TargetScan | -0.13 | 0 | NA | |
144 | hsa-miR-141-3p | IFFO2 | 5.02 | 0 | -0.91 | 0.00201 | MirTarget; TargetScan | -0.1 | 0.00019 | NA | |
145 | hsa-miR-141-3p | IGDCC4 | 5.02 | 0 | -1.99 | 0 | TargetScan; miRNATAP | -0.35 | 0 | NA | |
146 | hsa-miR-141-3p | IGF2BP2 | 5.02 | 0 | 0.95 | 0.14454 | MirTarget; TargetScan; miRNATAP | -0.31 | 0 | NA | |
147 | hsa-miR-141-3p | IGSF6 | 5.02 | 0 | 0.29 | 0.48351 | TargetScan | -0.26 | 0 | NA | |
148 | hsa-miR-141-3p | IGSF9B | 5.02 | 0 | -3.7 | 0 | TargetScan | -0.38 | 0 | NA | |
149 | hsa-miR-141-3p | IL18R1 | 5.02 | 0 | -0.49 | 0.12464 | MirTarget | -0.13 | 1.0E-5 | NA | |
150 | hsa-miR-141-3p | IL6R | 5.02 | 0 | -1.87 | 0 | MirTarget | -0.24 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL DEVELOPMENT | 79 | 1426 | 3.752e-17 | 1.746e-13 |
2 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 43 | 513 | 1.33e-15 | 3.094e-12 |
3 | REGULATION OF CELL DIFFERENTIATION | 77 | 1492 | 4.933e-15 | 6.847e-12 |
4 | NEUROGENESIS | 74 | 1402 | 5.886e-15 | 6.847e-12 |
5 | CELLULAR COMPONENT MORPHOGENESIS | 54 | 900 | 3.268e-13 | 2.243e-10 |
6 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 50 | 788 | 3.374e-13 | 2.243e-10 |
7 | CIRCULATORY SYSTEM DEVELOPMENT | 50 | 788 | 3.374e-13 | 2.243e-10 |
8 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 51 | 823 | 4.72e-13 | 2.745e-10 |
9 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 77 | 1672 | 1.817e-12 | 9.394e-10 |
10 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 68 | 1395 | 3.698e-12 | 1.721e-09 |
11 | VASCULATURE DEVELOPMENT | 36 | 469 | 4.178e-12 | 1.767e-09 |
12 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 58 | 1142 | 3.696e-11 | 1.433e-08 |
13 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 62 | 1275 | 4.298e-11 | 1.538e-08 |
14 | BLOOD VESSEL MORPHOGENESIS | 30 | 364 | 4.878e-11 | 1.621e-08 |
15 | TISSUE DEVELOPMENT | 69 | 1518 | 5.849e-11 | 1.814e-08 |
16 | POSITIVE REGULATION OF CELL DEVELOPMENT | 34 | 472 | 9.478e-11 | 2.756e-08 |
17 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 27 | 306 | 1.007e-10 | 2.758e-08 |
18 | REGULATION OF NEURON DIFFERENTIATION | 37 | 554 | 1.182e-10 | 3.055e-08 |
19 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 53 | 1021 | 1.309e-10 | 3.205e-08 |
20 | REGULATION OF CELL PROJECTION ORGANIZATION | 37 | 558 | 1.448e-10 | 3.37e-08 |
21 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 29 | 368 | 2.996e-10 | 6.504e-08 |
22 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 44 | 771 | 3.075e-10 | 6.504e-08 |
23 | REGULATION OF CELL DEVELOPMENT | 46 | 836 | 3.855e-10 | 7.798e-08 |
24 | NEURON PROJECTION MORPHOGENESIS | 30 | 402 | 5.442e-10 | 1.055e-07 |
25 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 30 | 408 | 7.744e-10 | 1.441e-07 |
26 | LOCOMOTION | 54 | 1114 | 1.029e-09 | 1.841e-07 |
27 | NEURON PROJECTION DEVELOPMENT | 35 | 545 | 1.092e-09 | 1.882e-07 |
28 | REGULATION OF CELL MORPHOGENESIS | 35 | 552 | 1.527e-09 | 2.537e-07 |
29 | NEURON DIFFERENTIATION | 46 | 874 | 1.598e-09 | 2.563e-07 |
30 | POSITIVE REGULATION OF GENE EXPRESSION | 71 | 1733 | 2.771e-09 | 4.298e-07 |
31 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 48 | 957 | 3.269e-09 | 4.906e-07 |
32 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 41 | 750 | 4.517e-09 | 6.369e-07 |
33 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 45 | 872 | 4.476e-09 | 6.369e-07 |
34 | NEURON PROJECTION GUIDANCE | 20 | 205 | 5.074e-09 | 6.745e-07 |
35 | ANGIOGENESIS | 24 | 293 | 4.979e-09 | 6.745e-07 |
36 | NEURON DEVELOPMENT | 38 | 687 | 1.26e-08 | 1.628e-06 |
37 | CELL PROJECTION ORGANIZATION | 44 | 902 | 3.528e-08 | 4.32e-06 |
38 | BIOLOGICAL ADHESION | 48 | 1032 | 3.494e-08 | 4.32e-06 |
39 | POSITIVE REGULATION OF CELL PROLIFERATION | 41 | 814 | 4.488e-08 | 5.355e-06 |
40 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 28 | 437 | 5.658e-08 | 6.582e-06 |
41 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 24 | 337 | 7.341e-08 | 8.332e-06 |
42 | REGULATION OF EXTENT OF CELL GROWTH | 13 | 101 | 9.978e-08 | 1.105e-05 |
43 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 36 | 689 | 1.285e-07 | 1.391e-05 |
44 | MUSCLE TISSUE DEVELOPMENT | 21 | 275 | 1.521e-07 | 1.587e-05 |
45 | CELL PART MORPHOGENESIS | 34 | 633 | 1.535e-07 | 1.587e-05 |
46 | MUSCLE STRUCTURE DEVELOPMENT | 27 | 432 | 1.621e-07 | 1.639e-05 |
47 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 22 | 303 | 1.853e-07 | 1.835e-05 |
48 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 19 | 232 | 2.031e-07 | 1.969e-05 |
49 | HEART DEVELOPMENT | 28 | 466 | 2.14e-07 | 2.032e-05 |
50 | STEM CELL DIFFERENTIATION | 17 | 190 | 2.549e-07 | 2.372e-05 |
51 | TAXIS | 27 | 464 | 6.628e-07 | 6.047e-05 |
52 | HEAD DEVELOPMENT | 35 | 709 | 7.337e-07 | 6.565e-05 |
53 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 15 | 162 | 8.376e-07 | 7.353e-05 |
54 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 35 | 724 | 1.185e-06 | 0.0001021 |
55 | EMBRYONIC MORPHOGENESIS | 29 | 539 | 1.255e-06 | 0.0001062 |
56 | MESENCHYME DEVELOPMENT | 16 | 190 | 1.293e-06 | 0.0001074 |
57 | CONNECTIVE TISSUE DEVELOPMENT | 16 | 194 | 1.702e-06 | 0.0001385 |
58 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 43 | 1004 | 1.726e-06 | 0.0001385 |
59 | SENSORY ORGAN DEVELOPMENT | 27 | 493 | 2.11e-06 | 0.0001664 |
60 | GROWTH | 24 | 410 | 2.522e-06 | 0.0001945 |
61 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 27 | 498 | 2.55e-06 | 0.0001945 |
62 | MESENCHYMAL CELL DIFFERENTIATION | 13 | 134 | 2.683e-06 | 0.0002014 |
63 | MEMBRANE DEPOLARIZATION | 9 | 61 | 2.983e-06 | 0.0002169 |
64 | REGULATION OF CHONDROCYTE DIFFERENTIATION | 8 | 46 | 2.974e-06 | 0.0002169 |
65 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 64 | 1805 | 3.246e-06 | 0.0002323 |
66 | REGULATION OF CELL ADHESION | 31 | 629 | 3.341e-06 | 0.0002356 |
67 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 59 | 1618 | 3.533e-06 | 0.0002453 |
68 | POSITIVE REGULATION OF LOCOMOTION | 24 | 420 | 3.816e-06 | 0.0002611 |
69 | REGULATION OF CARTILAGE DEVELOPMENT | 9 | 63 | 3.931e-06 | 0.0002651 |
70 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 63 | 1784 | 4.474e-06 | 0.0002974 |
71 | MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 14 | 5.127e-06 | 0.000336 |
72 | REGULATION OF DEVELOPMENTAL GROWTH | 19 | 289 | 5.498e-06 | 0.0003553 |
73 | POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 8 | 50 | 5.711e-06 | 0.000364 |
74 | MULTICELLULAR ORGANISMAL SIGNALING | 12 | 123 | 6.124e-06 | 0.0003851 |
75 | REGULATION OF AXONOGENESIS | 14 | 168 | 6.709e-06 | 0.0004163 |
76 | RESPONSE TO WOUNDING | 28 | 563 | 8.512e-06 | 0.000515 |
77 | EMBRYO DEVELOPMENT | 38 | 894 | 8.523e-06 | 0.000515 |
78 | REGULATION OF CELL SIZE | 14 | 172 | 8.801e-06 | 0.0005183 |
79 | EYE DEVELOPMENT | 20 | 326 | 8.767e-06 | 0.0005183 |
80 | MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 7 | 39 | 1.007e-05 | 0.0005859 |
81 | NEURON MIGRATION | 11 | 110 | 1.178e-05 | 0.0006764 |
82 | DEVELOPMENTAL GROWTH | 20 | 333 | 1.197e-05 | 0.0006792 |
83 | ORGAN MORPHOGENESIS | 36 | 841 | 1.278e-05 | 0.0007164 |
84 | REGULATION OF CELLULAR COMPONENT SIZE | 20 | 337 | 1.424e-05 | 0.0007888 |
85 | SKELETAL SYSTEM DEVELOPMENT | 24 | 455 | 1.458e-05 | 0.000798 |
86 | ACTIN FILAMENT BASED MOVEMENT | 10 | 93 | 1.548e-05 | 0.0008378 |
87 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 19 | 312 | 1.628e-05 | 0.0008709 |
88 | REGULATION OF MEMBRANE POTENTIAL | 20 | 343 | 1.838e-05 | 0.0009687 |
89 | STEM CELL DIVISION | 6 | 29 | 1.874e-05 | 0.0009687 |
90 | CARDIAC MUSCLE CELL CONTRACTION | 6 | 29 | 1.874e-05 | 0.0009687 |
91 | VASCULOGENESIS | 8 | 59 | 2.02e-05 | 0.001033 |
92 | CARDIOCYTE DIFFERENTIATION | 10 | 96 | 2.051e-05 | 0.001037 |
93 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 12 | 140 | 2.296e-05 | 0.001149 |
94 | NEGATIVE REGULATION OF CELL COMMUNICATION | 45 | 1192 | 2.493e-05 | 0.001234 |
95 | CELL MOTILITY | 35 | 835 | 2.621e-05 | 0.00127 |
96 | LOCALIZATION OF CELL | 35 | 835 | 2.621e-05 | 0.00127 |
97 | REGULATION OF EPITHELIAL CELL MIGRATION | 13 | 166 | 2.767e-05 | 0.001314 |
98 | POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 5 | 19 | 2.744e-05 | 0.001314 |
99 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 49 | 1360 | 3.544e-05 | 0.001665 |
100 | ACTIN FILAMENT BASED PROCESS | 23 | 450 | 3.59e-05 | 0.00167 |
101 | MUSCLE ORGAN DEVELOPMENT | 17 | 277 | 4.101e-05 | 0.001871 |
102 | EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 6 | 33 | 4.086e-05 | 0.001871 |
103 | INTRACELLULAR SIGNAL TRANSDUCTION | 54 | 1572 | 4.997e-05 | 0.002257 |
104 | REGULATION OF CELL PROLIFERATION | 52 | 1496 | 5.155e-05 | 0.002306 |
105 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 22 | 437 | 6.617e-05 | 0.002932 |
106 | CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 37 | 8.022e-05 | 0.003521 |
107 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 25 | 541 | 8.516e-05 | 0.003623 |
108 | TUBE MORPHOGENESIS | 18 | 323 | 8.565e-05 | 0.003623 |
109 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 25 | 541 | 8.516e-05 | 0.003623 |
110 | REGULATION OF STEM CELL DIFFERENTIATION | 10 | 113 | 8.384e-05 | 0.003623 |
111 | HINDBRAIN DEVELOPMENT | 11 | 137 | 9.088e-05 | 0.003692 |
112 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 60 | 1848 | 9.126e-05 | 0.003692 |
113 | HEART MORPHOGENESIS | 14 | 212 | 8.946e-05 | 0.003692 |
114 | SKELETAL MUSCLE ORGAN DEVELOPMENT | 11 | 137 | 9.088e-05 | 0.003692 |
115 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 27 | 609 | 8.929e-05 | 0.003692 |
116 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 39 | 1036 | 9.471e-05 | 0.003703 |
117 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 39 | 1036 | 9.471e-05 | 0.003703 |
118 | SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE | 4 | 13 | 9.394e-05 | 0.003703 |
119 | CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 5 | 24 | 9.246e-05 | 0.003703 |
120 | FOREBRAIN DEVELOPMENT | 19 | 357 | 0.0001007 | 0.003903 |
121 | ACTION POTENTIAL | 9 | 94 | 0.0001031 | 0.003937 |
122 | REGULATION OF ORGAN MORPHOGENESIS | 15 | 242 | 0.0001032 | 0.003937 |
123 | CARDIAC MUSCLE CELL DIFFERENTIATION | 8 | 74 | 0.000106 | 0.004012 |
124 | EPITHELIAL TO MESENCHYMAL TRANSITION | 7 | 56 | 0.0001138 | 0.004168 |
125 | MEMBRANE ASSEMBLY | 5 | 25 | 0.0001137 | 0.004168 |
126 | NEGATIVE REGULATION OF PHOSPHORYLATION | 21 | 422 | 0.0001136 | 0.004168 |
127 | OUTFLOW TRACT MORPHOGENESIS | 7 | 56 | 0.0001138 | 0.004168 |
128 | TUBE DEVELOPMENT | 25 | 552 | 0.0001168 | 0.004245 |
129 | VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 4 | 14 | 0.0001295 | 0.00467 |
130 | PROTEIN PHOSPHORYLATION | 36 | 944 | 0.0001378 | 0.00493 |
131 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 32 | 801 | 0.0001423 | 0.005056 |
132 | SYNAPSE ORGANIZATION | 11 | 145 | 0.0001509 | 0.005319 |
133 | METENCEPHALON DEVELOPMENT | 9 | 100 | 0.0001661 | 0.005811 |
134 | CARTILAGE DEVELOPMENT | 11 | 147 | 0.0001703 | 0.005913 |
135 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 30 | 740 | 0.0001788 | 0.006162 |
136 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 22 | 472 | 0.0001996 | 0.006828 |
137 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 9 | 103 | 0.000208 | 0.007066 |
138 | CELL CELL ADHESION | 26 | 608 | 0.0002127 | 0.007171 |
139 | CARDIAC CONDUCTION | 8 | 82 | 0.0002186 | 0.007318 |
140 | RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 4 | 16 | 0.0002281 | 0.007582 |
141 | POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 5 | 29 | 0.0002381 | 0.007858 |
142 | REGULATION OF FAT CELL DIFFERENTIATION | 9 | 106 | 0.0002584 | 0.008469 |
143 | CARDIAC SEPTUM DEVELOPMENT | 8 | 85 | 0.0002804 | 0.00896 |
144 | MEMBRANE BIOGENESIS | 5 | 30 | 0.0002812 | 0.00896 |
145 | AMINOGLYCAN BIOSYNTHETIC PROCESS | 9 | 107 | 0.0002773 | 0.00896 |
146 | REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 5 | 30 | 0.0002812 | 0.00896 |
147 | BONE DEVELOPMENT | 11 | 156 | 0.000286 | 0.009001 |
148 | MUSCLE CELL DIFFERENTIATION | 14 | 237 | 0.0002863 | 0.009001 |
149 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 60 | 1929 | 0.00029 | 0.009056 |
150 | REGULATION OF CELL GROWTH | 19 | 391 | 0.0003212 | 0.009965 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 36 | 629 | 1.304e-08 | 1.211e-05 |
2 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 51 | 1199 | 2.103e-07 | 9.77e-05 |
3 | CYTOSKELETAL PROTEIN BINDING | 38 | 819 | 1.099e-06 | 0.0003404 |
4 | REGULATORY REGION NUCLEIC ACID BINDING | 37 | 818 | 2.771e-06 | 0.0006437 |
5 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 20 | 328 | 9.592e-06 | 0.001485 |
6 | SEQUENCE SPECIFIC DNA BINDING | 42 | 1037 | 9.121e-06 | 0.001485 |
7 | ACTIN BINDING | 21 | 393 | 4.137e-05 | 0.005196 |
8 | SEMAPHORIN RECEPTOR ACTIVITY | 4 | 11 | 4.474e-05 | 0.005196 |
9 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 18 | 315 | 6.218e-05 | 0.006419 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL JUNCTION | 61 | 1151 | 1.778e-12 | 1.038e-09 |
2 | CELL PROJECTION | 75 | 1786 | 2.926e-10 | 8.544e-08 |
3 | SYNAPSE | 42 | 754 | 1.657e-09 | 3.227e-07 |
4 | NEURON PART | 55 | 1265 | 3.172e-08 | 4.631e-06 |
5 | NEURON PROJECTION | 43 | 942 | 3.201e-07 | 3.739e-05 |
6 | CELL LEADING EDGE | 22 | 350 | 2.104e-06 | 0.0002048 |
7 | CYTOSKELETON | 66 | 1967 | 1.37e-05 | 0.001143 |
8 | ACTIN CYTOSKELETON | 23 | 444 | 2.915e-05 | 0.001741 |
9 | CELL CELL JUNCTION | 21 | 383 | 2.842e-05 | 0.001741 |
10 | CELL PROJECTION PART | 38 | 946 | 2.98e-05 | 0.001741 |
11 | SITE OF POLARIZED GROWTH | 12 | 149 | 4.261e-05 | 0.002178 |
12 | SEMAPHORIN RECEPTOR COMPLEX | 4 | 11 | 4.474e-05 | 0.002178 |
13 | CELL SUBSTRATE JUNCTION | 21 | 398 | 4.964e-05 | 0.00223 |
14 | MICROTUBULE END | 5 | 22 | 5.918e-05 | 0.002469 |
15 | VOLTAGE GATED SODIUM CHANNEL COMPLEX | 4 | 14 | 0.0001295 | 0.004726 |
16 | ANCHORING JUNCTION | 23 | 489 | 0.0001257 | 0.004726 |
17 | LAMELLIPODIUM | 12 | 172 | 0.0001691 | 0.005809 |
18 | SODIUM CHANNEL COMPLEX | 4 | 17 | 0.0002937 | 0.009027 |
19 | MICROTUBULE PLUS END | 4 | 17 | 0.0002937 | 0.009027 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Cell_adhesion_molecules_.CAMs._hsa04514 | 12 | 145 | 3.257e-05 | 0.001694 | |
2 | Hippo_signaling_pathway_multiple_species_hsa04392 | 5 | 29 | 0.0002381 | 0.006191 | |
3 | Hippo_signaling_pathway_hsa04390 | 10 | 154 | 0.001014 | 0.01758 | |
4 | Ras_signaling_pathway_hsa04014 | 12 | 232 | 0.002368 | 0.03079 | |
5 | MAPK_signaling_pathway_hsa04010 | 13 | 295 | 0.006196 | 0.06444 | |
6 | Rap1_signaling_pathway_hsa04015 | 10 | 206 | 0.008179 | 0.06464 | |
7 | Wnt_signaling_pathway_hsa04310 | 8 | 146 | 0.008702 | 0.06464 | |
8 | Hedgehog_signaling_pathway_hsa04340 | 4 | 47 | 0.01382 | 0.08981 | |
9 | Apelin_signaling_pathway_hsa04371 | 7 | 137 | 0.01944 | 0.1123 | |
10 | PI3K_Akt_signaling_pathway_hsa04151 | 13 | 352 | 0.02382 | 0.1239 | |
11 | Jak_STAT_signaling_pathway_hsa04630 | 7 | 162 | 0.0427 | 0.2018 | |
12 | TNF_signaling_pathway_hsa04668 | 5 | 108 | 0.06357 | 0.2755 | |
13 | TGF_beta_signaling_pathway_hsa04350 | 4 | 84 | 0.0854 | 0.3259 | |
14 | ErbB_signaling_pathway_hsa04012 | 4 | 85 | 0.08829 | 0.3259 | |
15 | cAMP_signaling_pathway_hsa04024 | 7 | 198 | 0.09942 | 0.3259 | |
16 | Cell_cycle_hsa04110 | 5 | 124 | 0.1003 | 0.3259 | |
17 | Regulation_of_actin_cytoskeleton_hsa04810 | 7 | 208 | 0.1202 | 0.3532 | |
18 | Tight_junction_hsa04530 | 6 | 170 | 0.1223 | 0.3532 | |
19 | Cytokine_cytokine_receptor_interaction_hsa04060 | 8 | 270 | 0.1686 | 0.4614 | |
20 | Focal_adhesion_hsa04510 | 6 | 199 | 0.2031 | 0.517 | |
21 | Cellular_senescence_hsa04218 | 5 | 160 | 0.2116 | 0.517 | |
22 | AMPK_signaling_pathway_hsa04152 | 4 | 121 | 0.2187 | 0.517 | |
23 | Autophagy_animal_hsa04140 | 4 | 128 | 0.2484 | 0.5485 | |
24 | Gap_junction_hsa04540 | 3 | 88 | 0.2531 | 0.5485 | |
25 | FoxO_signaling_pathway_hsa04068 | 4 | 132 | 0.2658 | 0.5529 | |
26 | Calcium_signaling_pathway_hsa04020 | 5 | 182 | 0.2931 | 0.5862 | |
27 | Phospholipase_D_signaling_pathway_hsa04072 | 4 | 146 | 0.328 | 0.6316 | |
28 | p53_signaling_pathway_hsa04115 | 2 | 68 | 0.3909 | 0.6804 | |
29 | cGMP_PKG_signaling_pathway_hsa04022 | 4 | 163 | 0.4043 | 0.6804 | |
30 | Necroptosis_hsa04217 | 4 | 164 | 0.4087 | 0.6804 | |
31 | Sphingolipid_signaling_pathway_hsa04071 | 3 | 118 | 0.4147 | 0.6804 | |
32 | Adherens_junction_hsa04520 | 2 | 72 | 0.4187 | 0.6804 | |
33 | ECM_receptor_interaction_hsa04512 | 2 | 82 | 0.4851 | 0.7643 | |
34 | NF_kappa_B_signaling_pathway_hsa04064 | 2 | 95 | 0.5639 | 0.8581 | |
35 | mTOR_signaling_pathway_hsa04150 | 3 | 151 | 0.5776 | 0.8581 | |
36 | Neuroactive_ligand_receptor_interaction_hsa04080 | 5 | 278 | 0.6471 | 0.9095 | |
37 | Lysosome_hsa04142 | 2 | 123 | 0.7032 | 0.9432 | |
38 | Oocyte_meiosis_hsa04114 | 2 | 124 | 0.7074 | 0.9432 | |
39 | Apoptosis_hsa04210 | 2 | 138 | 0.7613 | 0.9469 | |
40 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 2 | 139 | 0.7648 | 0.9469 | |
41 | Phagosome_hsa04145 | 2 | 152 | 0.8064 | 0.9752 | |
42 | Endocytosis_hsa04144 | 2 | 244 | 0.9558 | 1 |